September 9, 2020
September 9, 2020 –The U.S. FDA has approved Qdolo® (tramadol) 5mg/mL oral solution, manufactured by Athena Biosciences. The drug is indicated to manage pain severe enough to require
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
GlobalReach Health
September 9, 2020
September 9, 2020 –The U.S. FDA has approved a new indication for Trelegy® ElliptaTM (fluticasone
furoate/umeclidinium/vilanterol) oral inhalation powder, manufactured by GlaxoSmithKline
September 7, 2020
September 7, 2020 –The U.S. FDA has approved GavretoTM (pralsetinib), manufactured by Roche, to treat
adults diagnosed with metastatic rearranged-during-transfection (RET) fusion-positive
September 1, 2020
September 1, 2020 –The U.S. FDA has approved the MiniMedTM 770G hybrid closed loop insulin pump
system, manufactured by Medtronic. According to the FDA, “it is the first legally marketed
August 31, 2020
August 31, 2020 – The U.S. FDA has approved Xaracoll® (bupivacaine HCl), an implant manufactured by
Innocoll Pharmaceuticals, to provide acute postsurgical pain relief for up to 24 hours
August 31, 2020
August 31, 2020 – Mylan and Biocon Biologics have launched SemgleeTM (insulin glargine injection) in vial
and pre-filled pen dosage forms. The product is FDA-approved to help control blood sugar
August 28, 2020
August 28, 2020 – The U.S. FDA has expanded its Emergency Use Authorization (EUA) for the investigational drug Veklury® (remdesivir), manufactured by Gilead. While not
August 28, 2020
August 28, 2020 – The U.S. FDA has approved Sogroya® (somapacitan-beco) injection 10mg/1.5mL
(6.7mg/mL), manufactured by Novo Nordisk, for the replacement of endogenous